Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West ...

The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

At close: May 30 at 5:29:33 PM GMT+2 ...

Among the medications that could be negotiable are blood thinner Xarelto (Januvia) which is used for Type 2 diabetes and Symbicort, an inhaler to treat Asthma and Chronic obstructive pulmonary ...